Kidney Cancer – Renal Cell Carcinoma
The Kidneys are essential organs that form part of the genito-urinary system. The kidneys filter the blood and the waste products are transferred through the ureters to be stored in the bladder as urine. Urine is then discharged through the urethra to empty the bladder.
The kidneys also produce three important hormones: erythropoitin (EPO), which triggers the production of red blood cells in bones; renin, which regu-lates blood pressure; and vitamin D, which helps regulate the body’s metabo-lism of calcium necessary for healthy bones.
Renal Cell Carcinoma (RCC)
There are several types of cancer that can affect the kidneys. Renal cell car-cinoma (RCC), is the most common form and accounts for approximately 85% of all kidney cancers. In RCC, malignant cells develop in the lining of the kidney’s tubules and typically grow into a mass called a tumour. Single tu-mors are the norm, although more than one tumour can develop within one or both kidneys. As with most cancers, the earlier kidney tumours are discov-ered, the better a patient’s chances for survival. Tumours discovered at an early stage often respond well to treatment. Survival rates in such cases are high. Tumours that have grown large or metastasised (spread) through the bloodstream or lymphatic system to other parts of the body are much more difficult to treat and present a greatly increased risk for mortality.
In Australia, Kidney cancers count for just over 3% of all malignancies diag-nosed in men and women each year.
Statistically New South Wales has one of the highest incidences of Kidney Cancer worldwide.
In order to accurately determine whether or not a patient has cancer, a phys-ical examination and a number of other tests are required so that the Doctor can rule out any other conditions.
Intravenous Pyelogram (IVP)
A special dye is injected your arm that travels through the bloodstream to the urinary tract, which in turn is then picked up through an x-ray. This process allows a doctor to see if there are any abnormalities in the kidney or any oth-er damage to the organ.
CT scans are special x-rays that show the internal organs of your body. Dyes may also be injected allowing the doctor to see the area more clearly.
More than half of all patients with RCC have haematuria or blood in their urine. Often this blood is present in such small amounts or so diffused in the urine that it cannot be seen with the naked eye (called microscopic haematu-ria). To detect haematuria a chemical test of the urine usually is prescribed. On occasion, cells found in the urine are examined under a microscope for abnormalities. This procedure is called urine cytology.
Another procedure typically used in the diagnosis of RCC involves microscopic examination and/or chemical analysis of the patient’s blood. These tests screen for indicators that may demonstrate the presence of cancer, such as:
Anaemia (too few red blood cells; caused by internal bleeding, a common cancer symptom)
Polycythaemia (too many red blood cells; sometimes caused by cancerous tumors in the kidney that trigger the release of EPO, a hormone that increas-es red blood cell production in bone marrow)
Hypercalcaemia (high blood calcium levels)and elevated liver enzymes (con-ditions characteristic of RCC)
Because blood in the urine can result from other health problems, the doctor may order a cystoscopy to determine precisely where the internal bleeding is occurring. In cystoscopy, a long, thin, rigid or flexible optical scope is inserted through the urethra and into the bladder. The doctor then makes a visual ex-amination of the urethra, bladder, and kidneys to locate the site of bleeding.
Fine Needle Biopsy
If a tumour has been diagnosed, the doctor may take a biopsy of cells to be examined in the laboratory.
There are four main categories that make up RCC tumours based on their ap-pearance under microscopic examination:
Mixed clear and granular
Sarcomatoid or spindle type
Generally the type of cancer cell indicates the relative aggressiveness of the disease.
‘Clear cell’ cancers look the least abnormal; they are round or polygon-shaped and contain an abundance of fat and sugar. The tumours they produce are yellow to orange in colour. Clear cell cancers are thought to be the least ag-gressive and respond better to treatment.
However, few tumors contain only clear cells. Darker ‘granular cells’ usually are present to some degree and have a larger, darker nucleus full of tiny pink granules called mitochondria. The tumours they produce tend to be grey to white in colour. Mitochondria are small, oval bodies that provide energy for cell growth. Their presence indicates a more aggressive form of cancer.
The most common form of tumour contains both clear and granular cells and is considered to be ‘mixed’. This indicates the most aggressive form of kidney cancer. Mixed tumours that contain spindle shaped, ‘sarcomatoid cells’ have the least favourable prognosis. Although tumors composed exclusively of spindle cells are uncommon, the presence of sarcomatoid cells indicates a form of cancer that grows and spreads quickly.
Staging of Kidney Cancers
As discussed with other malignancies, the Tumour, Node and Metastases sys-tem stages RCC tumours at four intervals:
Stage 1: Small tumours (less than 1 inch) without evidence of local invasion; no lymph node involvement and absence of distant disease
Stage 2: Tumours larger than 1 inch without evidence of local invasion; no lymph node involvement and absence of distant disease
Stage 3: Tumours of any size that involve one lymph node (less than 1 inch); tumours that invade the adrenal gland or surrounding renal tissues; tumours that invade the renal vein or the inferior vena cava
Stage 4: A mixed group including tumours that invade adjacent structures; any tumour that has evidence of distant spread; any tumour in which more than one lymph node is involved
There are a number of treatment options for Kidney cancer; the ideal treat-ment depends on a number of factors, including the extent of the tumour and the current health of the patient. Treatment options vary and these should be discussed with the doctor to identify which is the best course of treatment for individual patients. They include Surgery, Chemotherapy and Radiation Ther-apy.
The most common form of surgery for RCC, radical nephrectomy involves removal of the entire kidney, often along with the attached adrenal gland, surrounding fatty tissues and nearby lymph nodes (regional Lymphadenecto-my), depending upon how far the cancer has spread.
It may be possible to remove only the cancerous tissue and part of the kid-ney if the tumor is small and confined to the very top or bottom of the kid-ney. A partial nephrectomy may be the procedure of choice for patients with RCC in both kidneys and for those who have only one functioning kidney.
Laparoscopic techniques allow the kidney to be removed using three 1cm “key hole” incisions in the abdomen. Occasionally 1 or 2 additional retraction ports (usually 5mm only) may be required. The most favoured approach worldwide is the trans-peritoneal approach, due to the fact that it gives the most reliable outcome. Conversion to the standard open operation is easily accomplished, should technical difficulty be encountered.
Advantages of Laparoscopic Nephrectomy
The main advantage of laparoscopy is the reduction of pain and post-operative recovery time. The patients usually can mobilise unassisted two days post-op and often are ready for discharge at that time. Patients receiv-ing the open operation usually cannot walk until day 4 or 5 and are not ready for discharge until a week or 10 days after surgery.
Most patients after laparoscopic nephrectomy are able to return to normal ac-tivities by the end of the first week, while patients after the open operation usually take 6 to 8 weeks.
Recent results from multi-centre trials have shown this operation to be safe in the treatment of localised renal cancer, hence widening the indication for the operation.
What types of kidney disease are suitable for laparoscopic nephrectomy?
Most patients with benign kidney disease that requires nephrectomy are suit-able, although infected or inflammatory kidneys are more difficult hence the open conversion rate is higher.
Localised renal cell carcinomas with size up to 6cm are suitable. Larger tu-mours can be removed but there is lack of long-term results published in the medical literature to confirm this is a safe practice.
Patients with renal cysts that are symptomatic are ideally suited to laparo-scopic de-roofing, which is technically less demanding than nephrectomy hence are most suitable for surgeons learning this procedure.
Donor nephrectomy for living related renal transplantation is also suitable. Transplant centres offering this option to potential donors have reported sig-nificant increase in donor rate.
Disadvantages of Laparoscopic Nephrectomy
This operation is technically demanding and is associated with a steep learning curve.
The operating time is longer than open operation, although with experience this reduces significantly.
Problems associated with CO2 distension of the abdomen can cause problems such as shoulder pain, CO2 retention, possible embolisation and tumour spill-age, which have not occurred in renal cell carcinoma.
Overall, reported complications from laparoscopic nephrectomy are compa-rable to that of open surgery and the advantages usually outweigh the disad-vantages.
Radiation in the form of x-rays or other high-energy rays is used to shrink and kill cancer cells in some kidney cancer patients. The radiation is delivered as a focused beam (external beam radiotherapy) that is projected into the body through a linear accelerator.
Radiation therapy is used often as an adjuvant (follow-up) therapy to kill any cancer cells that may remain in the body after a radical or partial nephrecto-my. It also may be used as palliative therapy to lessen pain or bleeding in pa-tients with inoperable or widespread metastatic RCC.
Follow-up Care and Recurrent Kidney Cancer
Some patients who undergo surgery to remove a cancerous kidney or kidney tumours experience a recurrence of the disease. For this reason, patients usually undergo a regimen of follow-up examinations after surgery. These examinations include a complete physical examination, a chest x-ray, com-plete blood tests, and assessments of liver and kidney function. If the disease recurs but remains confined to a few small areas, additional surgery may be recommended. Radiation, biological, or chemotherapy also may be tried as an adjuvant or palliative (relief-giving) treatment.